Signal Pharmaceuticals
Industry: Company
DescriptionFounded: 1993 Parent organization: Celgene
Signal Pharmaceuticals List of Employees There's an exhaustive list of past and present employees! Get comprehensive information on the number of employees at Signal Pharmaceuticals. You can filter them based on skills, years of employment, job, education, department, and prior employment.
Signal Pharmaceuticals Salaries. You can even request information on how much does Signal Pharmaceuticals pay if you want to. Learn about salaries, pros and cons of working for Signal Pharmaceuticals directly from the past employees.
Find People by Employers You can rekindle an old relationship, reconnect with a long-lost friend, former boss, business acquaintance who might be useful in your new line of work. With our employee database, the possibilities are endless. All you have to do is type in a couple of keywords and we'll bring you the exact information you wanted!
10 Signal Pharmaceuticals employees in database. Find out everything there's to know about Signal Pharmaceuticals employees. We offer you a great deal of unbiased information from the internal database, personal records, and many other details that might be of interest to you.
Signal Pharmaceuticals Employees
Employee
Years
Job
Industry
David W. Anderson David W. Anderson's Signal Pharmaceuticals Experience March 1994 - October 1999
Job Entrepreneur in Residence at The University of Missouri
Industry Biotechnology
Experience
University of Missouri April 2015 - Present
Anderson Phoenix Consulting April 2010 - Present
IGNYTA, Inc. October 2011 - October 2014
City Hill Ventures September 2011 - August 2014
Eclipse Therapeutics October 2011 - December 2012
Cypress Bioscience March 2008 - March 2010
Proprius Pharmaceuticals May 2006 - March 2008
Graceland University July 2001 - May 2006
Celgene October 1999 - July 2001
Signal Pharmaceuticals March 1994 - October 1999
Skills
Drug Discovery and..., Molecular Diagnostics, Personalized Medicine, Drug Discovery, Oncology, Immunology, Biomarkers, Pharmacology, Clinical Development, Life Sciences, Biotechnology, Cancer, Genomics, Diagnostics, Pharmaceuticals, Biochemistry, Cell Biology, Translational Research, R&D, Microbiology, Cell Based Assays, Cell Culture, Cancer Research, Strategic Planning, Molecular Biology, Cell, Pharmaceutical Industry, Lifesciences, Antibodies, In Vitro, In Vivo, Biopharmaceuticals, Drug Development, Clinical Trials, High Throughput..., Genetics, Protein Chemistry, Virology, Monoclonal Antibodies, Translational Medicine, Bioinformatics, Stem Cells, GLP, Proteomics, Animal Models, Biomarker Discovery, CRO, Toxicology, Immunohistochemistry, DNA sequencing
Education
University of Colorado Anschutz Medical Campus 1978 — 1981
Postdoctoral Fellow, Cellular and Molecular Immunology
University of Missouri-Columbia School of Medicine 1974 — 1978
PhD, Immunology/Microbiology
Graceland University 1971 — 1974
BA, Biology and Chemistry (minor)
University of Missouri April 2015 - Present
Anderson Phoenix Consulting April 2010 - Present
IGNYTA, Inc. October 2011 - October 2014
City Hill Ventures September 2011 - August 2014
Eclipse Therapeutics October 2011 - December 2012
Cypress Bioscience March 2008 - March 2010
Proprius Pharmaceuticals May 2006 - March 2008
Graceland University July 2001 - May 2006
Celgene October 1999 - July 2001
Signal Pharmaceuticals March 1994 - October 1999
Skills
Drug Discovery and..., Molecular Diagnostics, Personalized Medicine, Drug Discovery, Oncology, Immunology, Biomarkers, Pharmacology, Clinical Development, Life Sciences, Biotechnology, Cancer, Genomics, Diagnostics, Pharmaceuticals, Biochemistry, Cell Biology, Translational Research, R&D, Microbiology, Cell Based Assays, Cell Culture, Cancer Research, Strategic Planning, Molecular Biology, Cell, Pharmaceutical Industry, Lifesciences, Antibodies, In Vitro, In Vivo, Biopharmaceuticals, Drug Development, Clinical Trials, High Throughput..., Genetics, Protein Chemistry, Virology, Monoclonal Antibodies, Translational Medicine, Bioinformatics, Stem Cells, GLP, Proteomics, Animal Models, Biomarker Discovery, CRO, Toxicology, Immunohistochemistry, DNA sequencing
Education
University of Colorado Anschutz Medical Campus 1978 — 1981
Postdoctoral Fellow, Cellular and Molecular Immunology
University of Missouri-Columbia School of Medicine 1974 — 1978
PhD, Immunology/Microbiology
Graceland University 1971 — 1974
BA, Biology and Chemistry (minor)
Aung Lwin Aung Lwin's Signal Pharmaceuticals Experience 1997 - 2000
Job Associate Director, Commercial Quality Control at AstraZeneca
Industry Pharmaceuticals
Experience
AstraZeneca, BMS, Amylin LLC August 2000 - Present
Signal Pharmaceuticals 1997 - 2000
Skills
GMP, Validation, Pharmaceutical Industry, FDA, 21 CFR Part 11, GxP, LIMS, Assay Development, Quality Control, Quality Assurance, Change Control, Computer System..., Bioassay, DOT Certified, IATA, Laboratory, Trackwise, Life Sciences, GLP, SOP, Biotechnology, Biopharmaceuticals, Chemistry, CRO, Clinical Development
Education
University of California, San Diego
Bachelor's degree
AstraZeneca, BMS, Amylin LLC August 2000 - Present
Signal Pharmaceuticals 1997 - 2000
Skills
GMP, Validation, Pharmaceutical Industry, FDA, 21 CFR Part 11, GxP, LIMS, Assay Development, Quality Control, Quality Assurance, Change Control, Computer System..., Bioassay, DOT Certified, IATA, Laboratory, Trackwise, Life Sciences, GLP, SOP, Biotechnology, Biopharmaceuticals, Chemistry, CRO, Clinical Development
Education
University of California, San Diego
Bachelor's degree
Bernd Stein's Signal Pharmaceuticals Experience September 1993 - August 2000
Job Biotechnology Professional
Industry Biotechnology
Experience
Self-employed June 2007 - Present
Celgene/Signal Research Division September 2000 - May 2007
Signal Pharmaceuticals September 1993 - August 2000
Skills
Oncology, preclinical drug..., Clinical Development, High Throughput..., Project Management, Validation, Science, Biotechnology, Pharmacology, Biopharmaceuticals, Biomarkers, Drug Discovery, Cancer, Target Identification, Lifesciences, Inflammation, Cell Signaling, Cell, Pharmaceutics, Pharmaceutical Industry, Life Sciences
Education
University of North Carolina at Chapel Hill School of Medicine 1991 — 1993
Post-doc, Signal Transduction
Duke University School of Medicine 1990 — 1991
Post-doc, Signal Transduction
Karlsruhe Institute of Technology (KIT) 1987 — 1990
PhD, Biology
Self-employed June 2007 - Present
Celgene/Signal Research Division September 2000 - May 2007
Signal Pharmaceuticals September 1993 - August 2000
Skills
Oncology, preclinical drug..., Clinical Development, High Throughput..., Project Management, Validation, Science, Biotechnology, Pharmacology, Biopharmaceuticals, Biomarkers, Drug Discovery, Cancer, Target Identification, Lifesciences, Inflammation, Cell Signaling, Cell, Pharmaceutics, Pharmaceutical Industry, Life Sciences
Education
University of North Carolina at Chapel Hill School of Medicine 1991 — 1993
Post-doc, Signal Transduction
Duke University School of Medicine 1990 — 1991
Post-doc, Signal Transduction
Karlsruhe Institute of Technology (KIT) 1987 — 1990
PhD, Biology
Naoki Sakurai's Signal Pharmaceuticals Experience 1996 - 1997
Job President & CEO at Tanabe Research Laboratories U.S.A., Inc.
Industry Pharmaceuticals
Experience
Tanabe Research Laboratories U.S.A., Inc. June 2011 - Present
Mitsubishi Tanabe Pharma Corporation April 2010 - June 2011
Mitsubishi Tanabe Pharma Corporation April 2009 - April 2010
Mitsubishi Tanabe Pharma October 2007 - March 2009
Tanabe Research Laboratories 2002 - 2007
Tanabe Seiyaku Co., Ltd. 1985 - 2007
Signal Pharmaceuticals 1996 - 1997
Skills
Drug Discovery, Antibodies, Research, Biotechnology, Biomarkers, Drug Development, Biologics, Infectious Diseases, Cancer, Cell, Oncology, Biopharmaceuticals, Technology Transfer, Stem Cells, Pharmaceutical Industry, Science, Clinical Development, Molecular Biology, Biochemistry, Cell Culture, Protein Chemistry, Purification, Assay Development, Immunology, Lifesciences, Vaccines, Pharmacology, Protein Purification, Genomics, High Throughput..., Commercialization, Cell Biology, Life Sciences
Education
Kyoto University
Ph.D., Microbiology
Kyoto University 1979 — 1985
BS, MS, Microbiology
Tanabe Research Laboratories U.S.A., Inc. June 2011 - Present
Mitsubishi Tanabe Pharma Corporation April 2010 - June 2011
Mitsubishi Tanabe Pharma Corporation April 2009 - April 2010
Mitsubishi Tanabe Pharma October 2007 - March 2009
Tanabe Research Laboratories 2002 - 2007
Tanabe Seiyaku Co., Ltd. 1985 - 2007
Signal Pharmaceuticals 1996 - 1997
Skills
Drug Discovery, Antibodies, Research, Biotechnology, Biomarkers, Drug Development, Biologics, Infectious Diseases, Cancer, Cell, Oncology, Biopharmaceuticals, Technology Transfer, Stem Cells, Pharmaceutical Industry, Science, Clinical Development, Molecular Biology, Biochemistry, Cell Culture, Protein Chemistry, Purification, Assay Development, Immunology, Lifesciences, Vaccines, Pharmacology, Protein Purification, Genomics, High Throughput..., Commercialization, Cell Biology, Life Sciences
Education
Kyoto University
Ph.D., Microbiology
Kyoto University 1979 — 1985
BS, MS, Microbiology
Jeffrey Falk's Signal Pharmaceuticals Experience August 1996 - July 1999
Job Director of Clincal Diagnostic Assay Development, R&D and Commercialization & Biomarker Discovery
Industry Biotechnology
Experience
Genoptix Medical Laboratory, a Novartis Company April 2014 - Present
MDxHealth November 2012 - April 2014
RiboMed Biotechnologies & RiboMed Clinical Services Laboratory November 2011 - September 2012
Aviva Systems Biology 2006 - September 2011
DNA Microarray September 2003 - September 2006
Chugai Biopharamceuticals (A Gen-Probe Affiliate) July 1999 - September 2002
Signal Pharmaceuticals August 1996 - July 1999
The Scripps Research Institute August 1990 - August 1996
Skills
Genomics, Molecular Biology, Epigenetics, DNA sequencing, Drug Discovery, Oncology, PCR, Assay Development, Protein Chemistry, Molecular Diagnostics, Bioinformatics, Biomarkers, Sequencing, Commercialization, Purification, ELISA, Biotechnology, Biopharmaceuticals, qPCR, Antibodies, Project Management, Product Development, Next Gen, Clinical Development, Research, Cross-functional Team..., Immunohistochemistry, Design Control, clia, DNA Sequencing
Education
Purdue University 1980 — 1986
PhD, Molecular Biology
Texas A&M University 1978 — 1980
MS, Biochemistry
Clark University 1974 — 1978
BS, Biology
Genoptix Medical Laboratory, a Novartis Company April 2014 - Present
MDxHealth November 2012 - April 2014
RiboMed Biotechnologies & RiboMed Clinical Services Laboratory November 2011 - September 2012
Aviva Systems Biology 2006 - September 2011
DNA Microarray September 2003 - September 2006
Chugai Biopharamceuticals (A Gen-Probe Affiliate) July 1999 - September 2002
Signal Pharmaceuticals August 1996 - July 1999
The Scripps Research Institute August 1990 - August 1996
Skills
Genomics, Molecular Biology, Epigenetics, DNA sequencing, Drug Discovery, Oncology, PCR, Assay Development, Protein Chemistry, Molecular Diagnostics, Bioinformatics, Biomarkers, Sequencing, Commercialization, Purification, ELISA, Biotechnology, Biopharmaceuticals, qPCR, Antibodies, Project Management, Product Development, Next Gen, Clinical Development, Research, Cross-functional Team..., Immunohistochemistry, Design Control, clia, DNA Sequencing
Education
Purdue University 1980 — 1986
PhD, Molecular Biology
Texas A&M University 1978 — 1980
MS, Biochemistry
Clark University 1974 — 1978
BS, Biology
Lisa Banh's Signal Pharmaceuticals Experience December 2007 - January 2009
Job student
Industry Biotechnology
Experience
Signal Pharmaceuticals December 2007 - January 2009
Aviva Biosciences Corp 2005 - 2007
Education
San Diego State University-California State University 2001 — 2004
Signal Pharmaceuticals December 2007 - January 2009
Aviva Biosciences Corp 2005 - 2007
Education
San Diego State University-California State University 2001 — 2004
Dinah Sah's Signal Pharmaceuticals Experience 1993 - 1999
Job Senior Vice President Neuroscience at Voyager Therapeutics
Industry Biotechnology
Experience
Voyager Therapeutics March 2014 - Present
Alnylam Pharmaceuticals 2010 - 2012
Alnylam Pharmaceuticals 2008 - 2010
Alnylam Pharmaceuticals 2005 - 2008
Biogen Idec 1999 - 2005
Signal Pharmaceuticals 1993 - 1999
Skills
Drug Discovery, Assay Development, Biotechnology, Lifesciences, Drug Development, Cell Culture, Technology Transfer, Pharmaceutical Industry, Pharmacology, In Vitro, Clinical Development, RNAi, Antibodies, Biopharmaceuticals, Cell, In Vivo, Protein Chemistry, IND, Medicinal Chemistry, Immunology, Biomarkers, Drug Delivery, Purification, Toxicology, Biochemistry, High Throughput..., Cell Biology, siRNA, Inflammation, Immunoassays, Animal Models, Transfection, Cancer, Neuroscience, Life Sciences
Education
Harvard University
PhD, Neurobiology
Massachusetts Institute of Technology
B.S., Biology
Voyager Therapeutics March 2014 - Present
Alnylam Pharmaceuticals 2010 - 2012
Alnylam Pharmaceuticals 2008 - 2010
Alnylam Pharmaceuticals 2005 - 2008
Biogen Idec 1999 - 2005
Signal Pharmaceuticals 1993 - 1999
Skills
Drug Discovery, Assay Development, Biotechnology, Lifesciences, Drug Development, Cell Culture, Technology Transfer, Pharmaceutical Industry, Pharmacology, In Vitro, Clinical Development, RNAi, Antibodies, Biopharmaceuticals, Cell, In Vivo, Protein Chemistry, IND, Medicinal Chemistry, Immunology, Biomarkers, Drug Delivery, Purification, Toxicology, Biochemistry, High Throughput..., Cell Biology, siRNA, Inflammation, Immunoassays, Animal Models, Transfection, Cancer, Neuroscience, Life Sciences
Education
Harvard University
PhD, Neurobiology
Massachusetts Institute of Technology
B.S., Biology
Mark Evan Goldman's Signal Pharmaceuticals Experience 1994 - 1999
Job Retired
Industry Photography
Experience
Captive Moments Photography July 2012 - Present
Burnham Institute for Medical Research July 2008 - July 2012
Hawaii Biotech 2000 - 2005
TorreyPines Therapeutics 2000 - 2001
Signal Pharmaceuticals 1994 - 1999
Ligand 1992 - 1994
Merck and Co. 1986 - 1992
Skills
Drug Discovery, Pharmacology, Biotechnology, Pharmaceutical Industry, Cancer, Small Molecules, Cross-functional Team..., Retired, Drug Development, Molecular Biology, Science, Immunology, Cell Culture, Biochemistry, Clinical Development, Lifesciences, Oncology, HPLC, Assay Development, Biopharmaceuticals, Protein Chemistry, Laboratory, R&D, Cell, Cell Biology, Neuroscience, Organic Chemistry, Analytical Chemistry, Technology Transfer, Chromatography, CRO, Drug Design, Commercialization, Biomarker Discovery, Life Sciences
Education
National Institutes of Health 1981 — 1986
Post-doc, Pharmacology and Natural Products
The University of Texas at Austin 1978 — 1981
PhD, Pharmacology
The George Washington University 1973 — 1976
BS, Zoology
Alex Hamilton HS 1969 — 1973
Regents diploma
UCSD
Captive Moments Photography July 2012 - Present
Burnham Institute for Medical Research July 2008 - July 2012
Hawaii Biotech 2000 - 2005
TorreyPines Therapeutics 2000 - 2001
Signal Pharmaceuticals 1994 - 1999
Ligand 1992 - 1994
Merck and Co. 1986 - 1992
Skills
Drug Discovery, Pharmacology, Biotechnology, Pharmaceutical Industry, Cancer, Small Molecules, Cross-functional Team..., Retired, Drug Development, Molecular Biology, Science, Immunology, Cell Culture, Biochemistry, Clinical Development, Lifesciences, Oncology, HPLC, Assay Development, Biopharmaceuticals, Protein Chemistry, Laboratory, R&D, Cell, Cell Biology, Neuroscience, Organic Chemistry, Analytical Chemistry, Technology Transfer, Chromatography, CRO, Drug Design, Commercialization, Biomarker Discovery, Life Sciences
Education
National Institutes of Health 1981 — 1986
Post-doc, Pharmacology and Natural Products
The University of Texas at Austin 1978 — 1981
PhD, Pharmacology
The George Washington University 1973 — 1976
BS, Zoology
Alex Hamilton HS 1969 — 1973
Regents diploma
UCSD
Silke Thode's Signal Pharmaceuticals Experience November 1996 - July 1999
Job Director, Clinical Research at Advanced Bionics
Industry Pharmaceuticals
Experience
Advanced Bionics June 2015 - Present
Glaukos Corporation July 2012 - June 2015
Aptiv Solutions September 2009 - July 2012
Averion International (now part of Aptiv Solutions) June 2007 - September 2009
Integrium February 2004 - May 2007
Iconix Biosciences August 1999 - February 2004
Signal Pharmaceuticals November 1996 - July 1999
Skills
Clinical Trials, CRO, CTMS, GCP, Clinical Development, Clinical Operations, Clinical Monitoring, Clinical Research, Regulatory Submissions, FDA, ICH-GCP, Clinical Data Management, Sop, Drug Development
Education
University of Cologne 1980 — 1992
PhD, Biology
Advanced Bionics June 2015 - Present
Glaukos Corporation July 2012 - June 2015
Aptiv Solutions September 2009 - July 2012
Averion International (now part of Aptiv Solutions) June 2007 - September 2009
Integrium February 2004 - May 2007
Iconix Biosciences August 1999 - February 2004
Signal Pharmaceuticals November 1996 - July 1999
Skills
Clinical Trials, CRO, CTMS, GCP, Clinical Development, Clinical Operations, Clinical Monitoring, Clinical Research, Regulatory Submissions, FDA, ICH-GCP, Clinical Data Management, Sop, Drug Development
Education
University of Cologne 1980 — 1992
PhD, Biology
Brad Gordon's Signal Pharmaceuticals Experience 1994 - 2000
Job CEO at Boundary Ventures LLC
Industry Management Consulting
Experience
Boundary Ventures LLC V.P. Finance and Corporate PlanningCelgene2000 - 2007
Signal Pharmaceuticals 1994 - 2000
Viagene, Inc. 1987 - 1994
EMC Venture Partners 1981 - 1986
Skills
Start-ups, Mergers & Acquisitions, Corporate Development, Corporate Finance, Strategic Planning, Business Development, In/out Licensing, Venture Capital, Due Diligence, Project Management, Management Consulting, Leadership, Public Speaking, Private Equity, Entrepreneurship
Education
NMSU
Honorary Doctorate, Commencement Speaker
USC 1978 — 1981
Master of Business Administration (MBA), Finance, New Venture Mgt., Additional year of extended studies in Finance
NMSU 1976 — 1978
Bachelor of Business Administration (BBA), Marketing, Graduated third in College of Business
Indiana University Bloomington 1972 — 1975
Boundary Ventures LLC V.P. Finance and Corporate PlanningCelgene2000 - 2007
Signal Pharmaceuticals 1994 - 2000
Viagene, Inc. 1987 - 1994
EMC Venture Partners 1981 - 1986
Skills
Start-ups, Mergers & Acquisitions, Corporate Development, Corporate Finance, Strategic Planning, Business Development, In/out Licensing, Venture Capital, Due Diligence, Project Management, Management Consulting, Leadership, Public Speaking, Private Equity, Entrepreneurship
Education
NMSU
Honorary Doctorate, Commencement Speaker
USC 1978 — 1981
Master of Business Administration (MBA), Finance, New Venture Mgt., Additional year of extended studies in Finance
NMSU 1976 — 1978
Bachelor of Business Administration (BBA), Marketing, Graduated third in College of Business
Indiana University Bloomington 1972 — 1975
Deloitte
PwC
Ernst & Young
Walgreens
Procter & Gamble
KPMG
PricewaterhouseCoopers
EY